-
公开(公告)号：US09393416B2
公开(公告)日：2016-07-19
申请号：US14144307
申请日：2013-12-30
Applicant: Medtronic, Inc.
Inventor： Ethan A. Rooney , Gary W. King , Carl D. Wahlstrand , Kenneth T. Heruth , Thomas E. Cross, Jr. , Paul W. Wacnik , Richard T. Stone
CPC classification number: A61N1/36071 , A61N1/0531 , A61N1/0534 , A61N1/0553 , A61N1/0558 , A61N1/36021 , A61N1/37205 , A61N1/37211 , A61N1/375 , A61N1/3756
Abstract: Delivery of peripheral nerve field stimulation (PNFS) in combination with one or more other therapies is described. The other therapy delivered in combination with PNFS may be, for example, a different type of neurostimulation, such as spinal cord stimulation (SCS), or a drug. PNFS and the other therapy may be delivered simultaneously, in an alternating fashion, according to a schedule, and/or selectively, e.g., in response to a request received from a patient or clinician. A combination therapy that includes PNFS may be able to more completely address complex or multifocal pain than would be possible through delivery of either PNFS or other therapies alone. Further, the combination of PNFS with one or more other therapies may reduce the likelihood that neural accommodation will impair the perceived effectiveness PNFS or the other therapies.
Abstract translation: 描述了外周神经区域刺激（PNFS）与一种或多种其他疗法的结合。 与PNFS组合递送的另一疗法可以是例如不同类型的神经刺激，例如脊髓刺激（SCS）或药物。 PNFS和其他治疗可以根据时间表以交替方式同时递送，和/或选择性地，例如响应于从患者或临床医生接收到的请求。 包括PNFS的联合治疗可能能够更全面地解决复杂或多焦点疼痛，而不仅仅是通过传送PNFS或其他疗法来实现。 此外，PNFS与一种或多种其它疗法的组合可以降低神经调节可能损害所感知的有效性PNFS或其他疗法的可能性。
-
公开(公告)号：US09393408B2
公开(公告)日：2016-07-19
申请号：US14582817
申请日：2014-12-24
Applicant: Medtronic, Inc.
Inventor： John Kast , Carl D. Wahlstrand , Mark J. Conroy , Erik R. Scott
IPC: A61N1/08 , A61N1/05 , A61N1/375 , A61N1/378 , H01M2/02 , H01M2/22 , H01M2/26 , H01M2/30 , H01M10/04 , H01M10/052 , H01M10/0587 , A61N1/36 , A61B19/00 , A61N1/37 , H01M2/04 , H01M2/10
CPC classification number: G01R33/56572 , A61B5/055 , A61B34/10 , A61N1/05 , A61N1/0529 , A61N1/0551 , A61N1/08 , A61N1/086 , A61N1/3605 , A61N1/36125 , A61N1/3718 , A61N1/375 , A61N1/3758 , A61N1/378 , G01R33/3875 , H01M2/0217 , H01M2/026 , H01M2/0275 , H01M2/0285 , H01M2/0404 , H01M2/1066 , H01M2/22 , H01M2/263 , H01M2/30 , H01M10/0431 , H01M10/052 , H01M10/0525 , H01M10/0587 , H01M2220/30 , Y10T29/49 , Y10T29/49002
Abstract: A method of manufacturing an implantable medical device having reduced MRI image distortion, includes producing an implantable medical device. The implantable medical device has a configuration that comprises a housing and one or more internal components disposed within the housing. The configuration is based upon a design process that includes creating a first prototype, determining the aggregate relative magnetic permeability of the first prototype, and modifying the design of the first prototype by at least one of (a) selecting and adding a diamagnetic shimming material to the first prototype or (b) repositioning one or more internal components of the first prototype. Modifying the design results in a modified design that is the configuration for the implantable medical device.
Abstract translation: 制造具有降低的MRI图像失真的可植入医疗装置的方法包括制造可植入医疗装置。 可植入医疗装置具有包括壳体和设置在壳体内的一个或多个内部部件的构造。 该配置基于设计过程，其包括创建第一原型，确定第一原型的聚集相对磁导率，以及通过以下中的至少一个修改第一原型的设计：（a）选择并添加抗磁性匀整材料至 第一个原型或（b）重新定位第一个原型的一个或多个内部组件。 修改设计会导致修改后的设计，即可植入医疗设备的配置。
-
公开(公告)号：US09227055B2
公开(公告)日：2016-01-05
申请号：US14103495
申请日：2013-12-11
Applicant: Medtronic, Inc.
Inventor： Carl D. Wahlstrand , Robert M. Skime , Gregory A. Hrdlicka , James M. Olsen , Stephen L. Bolea
CPC classification number: A61N1/08 , A61N1/05 , A61N1/0534 , A61N1/0551 , A61N1/086 , A61N1/36071
Abstract: A medical lead is provided for use in a pulse stimulation system of the type which includes a pulse generator for producing electrical stimulation therapy. The lead comprises an elongate insulating body and at least one electrical conductor within the insulating body. The conductor has a proximal end configured to be electrically coupled to the pulse generator and has a DC resistance in the range of 375-2000 ohms. At least one distal electrode is coupled to the conductor.
-
54.发明申请公开(公告)号：US20150283389A1
公开(公告)日：2015-10-08
申请号：US14746480
申请日：2015-06-22
Applicant: Medtronic, Inc.
Inventor： Richard T. Stone , Warren W. Ball , Carl D. Wahlstrand , Steven M. Goetz , Lynn M. Otten
IPC: A61N1/372 , G06F3/0481 , G06F3/0482 , A61N1/36
CPC classification number: A61N1/37247 , A61N1/0529 , A61N1/0531 , A61N1/0534 , A61N1/0553 , A61N1/3605 , A61N1/3606 , A61N1/36082 , A61N1/36125 , A61N1/36146 , A61N1/36153 , A61N1/36157 , A61N1/36192 , G06F3/04815 , G06F3/04817 , G06F3/0482 , G06F19/00 , G06F19/321 , G06F19/325 , G16H50/50
Abstract: The disclosure describes a method and system that allows a user to configure electrical stimulation therapy by defining a three-dimensional (3D) stimulation field. After a stimulation lead is implanted in a patient, a clinician manipulates the 3D stimulation field in a 3D environment to encompass desired anatomical regions of the patient. In this manner, the clinician determines which anatomical regions to stimulate, and the system generates the necessary stimulation parameters. In some cases, a lead icon representing the implanted lead is displayed to show the clinician where the lead is relative to the 3D anatomical regions of the patient.
Abstract translation: 本公开描述了允许用户通过定义三维（3D）刺激场来配置电刺激治疗的方法和系统。 在将刺激引线植入患者体内之后，临床医生操纵3D环境中的3D刺激场以包围病人的所需解剖区域。 以这种方式，临床医生确定要刺激的解剖区域，并且系统产生必要的刺激参数。 在一些情况下，显示代表植入引线的引线图标，以显示临床医生铅的相对于患者的3D解剖区域。
-
公开(公告)号：US20150224251A1
公开(公告)日：2015-08-13
申请号：US14696248
申请日：2015-04-24
Applicant: Medtronic, Inc.
Inventor： Ethan A. Rooney , Carl D. Wahlstrand , Gary W. King , Thomas E. Cross, JR. , Kenneth T. Heruth , Paul W. Wacnik , Jeffrey S. Evanson
CPC classification number: A61N1/36021 , A61M5/14 , A61M5/142 , A61M2205/054 , A61N1/0531 , A61N1/0534 , A61N1/0553 , A61N1/0558 , A61N1/36017 , A61N1/36071 , A61N1/37211 , A61N1/375
Abstract: Delivery of peripheral nerve field stimulation (PNFS) in combination with one or more other therapies is described. The other therapy delivered in combination with PNFS may be, for example, a different type of neurostimulation, such as spinal cord stimulation (SCS), or a drug. PNFS and the other therapy may be delivered simultaneously, in an alternating fashion, according to a schedule, and/or selectively, e.g., in response to a request received from a patient or clinician. A combination therapy that includes PNFS may be able to more completely address complex or multifocal pain than would be possible through delivery of either PNFS or other therapies alone. Further, the combination of PNFS with one or more other therapies may reduce the likelihood that neural accommodation will impair the perceived effectiveness PNFS or the other therapies.
Abstract translation: 描述了外周神经区域刺激（PNFS）与一种或多种其他疗法的结合。 与PNFS组合递送的另一疗法可以是例如不同类型的神经刺激，例如脊髓刺激（SCS）或药物。 PNFS和其他治疗可以根据时间表以交替方式同时递送，和/或选择性地，例如响应于从患者或临床医生接收到的请求。 包括PNFS的联合治疗可能能够更全面地解决复杂或多焦点疼痛，而不仅仅是通过传送PNFS或其他疗法来实现。 此外，PNFS与一种或多种其它疗法的组合可以降低神经调节可能损害所感知的有效性PNFS或其他疗法的可能性。
-
Patent Agency Ranking
公开(公告)号：US09020599B2
公开(公告)日：2015-04-28
申请号：US14109049
申请日：2013-12-17
Applicant: Medtronic, Inc.
Inventor： Ethan A. Rooney , Carl D. Wahlstrand , Gary W. King , Thomas E. Cross, Jr. , Kenneth T. Heruth , Paul W. Wacnik , Jeffrey S. Evanson
CPC classification number: A61N1/36021 , A61M5/14 , A61M5/142 , A61M2205/054 , A61N1/0531 , A61N1/0534 , A61N1/0553 , A61N1/0558 , A61N1/36017 , A61N1/36071 , A61N1/37211 , A61N1/375
Abstract: Delivery of peripheral nerve field stimulation (PNFS) in combination with one or more other therapies is described. The other therapy delivered in combination with PNFS may be, for example, a different type of neurostimulation, such as spinal cord stimulation (SCS), or a drug. PNFS and the other therapy may be delivered simultaneously, in an alternating fashion, according to a schedule, and/or selectively, e.g., in response to a request received from a patient or clinician. A combination therapy that includes PNFS may be able to more completely address complex or multifocal pain than would be possible through delivery of either PNFS or other therapies alone. Further, the combination of PNFS with one or more other therapies may reduce the likelihood that neural accommodation will impair the perceived effectiveness PNFS or the other therapies.
Abstract translation: 描述了外周神经区域刺激（PNFS）与一种或多种其他疗法的结合。 与PNFS组合递送的另一疗法可以是例如不同类型的神经刺激，例如脊髓刺激（SCS）或药物。 PNFS和其他治疗可以根据时间表以交替方式同时递送，和/或选择性地，例如响应于从患者或临床医生接收到的请求。 包括PNFS的联合治疗可能能够更全面地解决复杂或多焦点疼痛，而不仅仅是通过传送PNFS或其他疗法来实现。 此外，PNFS与一种或多种其它疗法的组合可以降低神经调节可能损害所感知的有效性PNFS或其他疗法的可能性。
-
公开(公告)号：US08923969B2
公开(公告)日：2014-12-30
申请号：US14040136
申请日：2013-09-27
Applicant: Medtronic, Inc.
Inventor： John Kast , Carl D. Wahlstrand , Mark J. Conroy , Erik R. Scott
IPC: A61N1/05 , H01M10/0587 , H01M2/26 , H01M10/052 , H01M2/30 , H01M2/22 , A61N1/36 , H01M2/02 , A61N1/378 , A61B19/00 , H01M10/04 , H01M2/10 , A61N1/375 , A61N1/08 , H01M2/04 , A61N1/37
CPC classification number: G01R33/56572 , A61B5/055 , A61B34/10 , A61N1/05 , A61N1/0529 , A61N1/0551 , A61N1/08 , A61N1/086 , A61N1/3605 , A61N1/36125 , A61N1/3718 , A61N1/375 , A61N1/3758 , A61N1/378 , G01R33/3875 , H01M2/0217 , H01M2/026 , H01M2/0275 , H01M2/0285 , H01M2/0404 , H01M2/1066 , H01M2/22 , H01M2/263 , H01M2/30 , H01M10/0431 , H01M10/052 , H01M10/0525 , H01M10/0587 , H01M2220/30 , Y10T29/49 , Y10T29/49002
Abstract: An implantable medical device includes a housing formed of a first material and a first electronic component provided within the housing. The implantable medical device also includes a second material provided in contact with at least a portion of the housing. At least one of the housing and the first electronic component has a magnetic permeability in a magnetic field that differs from the magnetic permeability of water. The second material is provided in an amount effective to reduce MRI image distortion caused by the implantable medical device.
Abstract translation: 可植入医疗装置包括由第一材料形成的壳体和设置在壳体内的第一电子部件。 可植入医疗装置还包括与壳体的至少一部分接触设置的第二材料。 壳体和第一电子部件中的至少一个在与磁导率不同的磁场中具有磁导率。 提供第二材料以有效减少由可植入医疗装置引起的MRI图像失真的量。
-
公开(公告)号：US20140336737A1
公开(公告)日：2014-11-13
申请号：US14341330
申请日：2014-07-25
Applicant: MEDTRONIC, INC.
Inventor： Carl D. Wahlstrand , Robert M. Skime , Gregory A. Hrdlicka , James M. Olsen , Stephen L. Bolea
CPC classification number: A61N1/08 , A61N1/05 , A61N1/0534 , A61N1/0551 , A61N1/086 , A61N1/36071
Abstract: A medical lead is provided for use in a pulse stimulation system of the type which includes a pulse generator for producing electrical stimulation therapy. The lead comprises an elongate insulating body and at least one electrical conductor within the insulating body. The conductor has a proximal end configured to be electrically coupled to the pulse generator and has a DC resistance in the range of 375-2000 ohms. At least one distal electrode is coupled to the conductor.
Abstract translation: 提供了一种用于包括用于产生电刺激治疗的脉冲发生器的脉冲刺激系统的医疗引线。 引线包括细长绝缘体和绝缘体内的至少一个电导体。 导体具有被配置为电耦合到脉冲发生器的近端，并具有在375-2000欧姆范围内的直流电阻。 至少一个远端电极耦合到导体。
-
公开(公告)号：US20140200643A1
公开(公告)日：2014-07-17
申请号：US14215822
申请日：2014-03-17
Applicant: Medtronic, Inc.
Inventor： Carl D. Wahlstrand , Gregory A. Hrdlicka , Thomas E. Cross, Jr. , Thomas Barry Hoegh , James M. Olsen , Stephen L. Bolea
CPC classification number: A61N1/08 , A61N1/05 , A61N1/0534 , A61N1/0553 , A61N1/086
Abstract: A stimulation lead is configured to be implanted into a patient's body and includes at least one distal stimulation electrode and at least one conductive filer electrically coupled to the distal stimulation electrode. A jacket is provided for housing the conductive filer and providing a path distributed along at least a portion of the length of the lead for conducting induced RF energy from the filer to the patient's body.
Abstract translation: 刺激引线被配置为植入患者体内，并且包括至少一个远端刺激电极和至少一个电连接到远端刺激电极的导电滤波器。 提供外壳以容纳导电滤波器并且提供沿着引线长度的至少一部分分布的路径，以将感应的RF能量从滤波器传导到患者身体。
-
公开(公告)号：US20140107743A1
公开(公告)日：2014-04-17
申请号：US14103495
申请日：2013-12-11
Applicant: Medtronic, Inc.
Inventor： Carl D. Wahlstrand , Robert M. Skime , Gregory A. Hrdlicka , James M. Olsen , Stephen L. Bolea
CPC classification number: A61N1/08 , A61N1/05 , A61N1/0534 , A61N1/0551 , A61N1/086 , A61N1/36071
Abstract: A medical lead is provided for use in a pulse stimulation system of the type which includes a pulse generator for producing electrical stimulation therapy. The lead comprises an elongate insulating body and at least one electrical conductor within the insulating body. The conductor has a proximal end configured to be electrically coupled to the pulse generator and has a DC resistance in the range of 375-2000 ohms. At least one distal electrode is coupled to the conductor.
Abstract translation: 提供了一种用于包括用于产生电刺激治疗的脉冲发生器的脉冲刺激系统的医疗引线。 引线包括细长绝缘体和绝缘体内的至少一个电导体。 导体具有被配置为电耦合到脉冲发生器的近端，并具有在375-2000欧姆范围内的直流电阻。 至少一个远端电极耦合到导体。
-
-
-
-
-
-
-
-
-
Search Results
81
records
(took 0.035 seconds)
